IBC Services Expansion IBC Services Expansion: Quorum Review IRB launched integrated institutional biosafety committee (IBC) review and administration in 2020, signaling demand for biosafety oversight alongside ethics review; this presents cross-sell potential to sponsors requiring streamlined governance for drug and device trials.

Acquisition Synergy Acquisition Synergy: Since Advarra acquired Quorum Review in 2019, the combined platform can broaden access to a larger sponsor network; leverage cross-selling across Advarra's client base and highlight centralized IRB capabilities.

Unified Sponsor Support Unified Sponsor Support: Quorum provides a single point of contact for sponsors and a secure web portal for submissions and status updates, a compelling value proposition for sponsors seeking efficient, predictable regulatory timelines.

eConsent Innovation eConsent Innovation: Q Consent cloud-based eConsent launched in 2018, indicating commitment to digitizing consent and trial participation; this can be a differentiator for sponsors seeking modern, compliant consent workflows.

Central IRB Leader Central IRB Leader: Quorum Review IRB is the largest and most preferred central IRB with AAHRPP accreditation and high throughput (15 board meetings per week), appealing to sponsors needing fast turnarounds and reliable multi-site trial governance.